37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS 2021): 13–15 October, 2021
- 1 November 2021
- journal article
- editorial
- Published by Springer Science and Business Media LLC in Pharmaceutical Medicine
- Vol. 35 (6), 367-370
- https://doi.org/10.1007/s40290-021-00411-x
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Multiple sclerosis: doubling down on MHCTrends in Genetics, 2021
- Early treatment delays long-term disability accrual in RRMS: Results from the BMSD networkMultiple Sclerosis Journal, 2021
- Treatment Switching and Discontinuation Over 20 Years in the Big Multiple Sclerosis Data NetworkFrontiers in Neurology, 2021
- COVID-19 in people with multiple sclerosis: A global data sharing initiativeMultiple Sclerosis Journal, 2020
- Encephalitogenic potential of the myelin basic protein peptide (amino acids 83–99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligandNature Medicine, 2000